BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21471194)

  • 1. Lipid peroxidation modification of protein generates Nepsilon-(4-oxononanoyl)lysine as a pro-inflammatory ligand.
    Shibata T; Shimozu Y; Wakita C; Shibata N; Kobayashi M; Machida S; Kato R; Itabe H; Zhu X; Sayre LM; Uchida K
    J Biol Chem; 2011 Jun; 286(22):19943-57. PubMed ID: 21471194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 4-hydroxy-2-nonenal-histidine adducts that serve as ligands for human lectin-like oxidized LDL receptor-1.
    Kumano-Kuramochi M; Shimozu Y; Wakita C; Ohnishi-Kameyama M; Shibata T; Matsunaga S; Takano-Ishikawa Y; Watanabe J; Goto M; Xie Q; Komba S; Uchida K; Machida S
    Biochem J; 2012 Feb; 442(1):171-80. PubMed ID: 22077443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized LDL, LOX-1 and atherosclerosis.
    Mitra S; Goyal T; Mehta JL
    Cardiovasc Drugs Ther; 2011 Oct; 25(5):419-29. PubMed ID: 21947818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid peroxidation generates body odor component trans-2-nonenal covalently bound to protein in vivo.
    Ishino K; Wakita C; Shibata T; Toyokuni S; Machida S; Matsuda S; Matsuda T; Uchida K
    J Biol Chem; 2010 May; 285(20):15302-15313. PubMed ID: 20215107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent binding of oxidized cholesteryl esters to protein: implications for oxidative modification of low density lipoprotein and atherosclerosis.
    Kawai Y; Saito A; Shibata N; Kobayashi M; Yamada S; Osawa T; Uchida K
    J Biol Chem; 2003 Jun; 278(23):21040-9. PubMed ID: 12663661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins.
    Uchida K; Kanematsu M; Morimitsu Y; Osawa T; Noguchi N; Niki E
    J Biol Chem; 1998 Jun; 273(26):16058-66. PubMed ID: 9632657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRP is a novel ligand for the oxidized LDL receptor LOX-1.
    Shih HH; Zhang S; Cao W; Hahn A; Wang J; Paulsen JE; Harnish DC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1643-50. PubMed ID: 19252093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand specificity of LOX-1, a novel endothelial receptor for oxidized low density lipoprotein.
    Moriwaki H; Kume N; Sawamura T; Aoyama T; Hoshikawa H; Ochi H; Nishi E; Masaki T; Kita T
    Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1541-7. PubMed ID: 9763524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.
    Lu J; Yang JH; Burns AR; Chen HH; Tang D; Walterscheid JP; Suzuki S; Yang CY; Sawamura T; Chen CH
    Circ Res; 2009 Mar; 104(5):619-27. PubMed ID: 19150883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.
    Sakata N; Uesugi N; Takebayashi S; Nagai R; Jono T; Horiuchi S; Takeya M; Itabe H; Takano T; Myint T; Taniguchi N
    Cardiovasc Res; 2001 Feb; 49(2):466-75. PubMed ID: 11164857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease.
    Dunn S; Vohra RS; Murphy JE; Homer-Vanniasinkam S; Walker JH; Ponnambalam S
    Biochem J; 2008 Jan; 409(2):349-55. PubMed ID: 18092947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of acrolein-specific adducts generated during lipid peroxidation-modification of proteins in vitro: identification of N(τ)-(3-propanal)histidine as the major adduct.
    Maeshima T; Honda K; Chikazawa M; Shibata T; Kawai Y; Akagawa M; Uchida K
    Chem Res Toxicol; 2012 Jul; 25(7):1384-92. PubMed ID: 22716039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect and mechanism of PCSK9 on lectin-like oxidized low-density lipoprotein receptor-1 mediated oxidized low-density lipoprotein uptake by THP-1 derived macrophages].
    Bao HL; Liao FJ; Fang L; Zhong F; Liu W; Li JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 May; 47(5):367-373. PubMed ID: 31142080
    [No Abstract]   [Full Text] [Related]  

  • 14. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation.
    Steinbrecher UP; Lougheed M; Kwan WC; Dirks M
    J Biol Chem; 1989 Sep; 264(26):15216-23. PubMed ID: 2768257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LOX-1 receptor: A potential link in atherosclerosis and cancer.
    Balzan S; Lubrano V
    Life Sci; 2018 Apr; 198():79-86. PubMed ID: 29462603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis and post-translational processing of lectin-like oxidized low density lipoprotein receptor-1 (LOX-1). N-linked glycosylation affects cell-surface expression and ligand binding.
    Kataoka H; Kume N; Miyamoto S; Minami M; Murase T; Sawamura T; Masaki T; Hashimoto N; Kita T
    J Biol Chem; 2000 Mar; 275(9):6573-9. PubMed ID: 10692464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
    Ishiyama J; Taguchi R; Yamamoto A; Murakami K
    Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dominant-negative lox-1 blocks homodimerization of wild-type lox-1-induced cell proliferation through extracellular signal regulated kinase 1/2 activation.
    Tanigawa H; Miura S; Matsuo Y; Fujino M; Sawamura T; Saku K
    Hypertension; 2006 Aug; 48(2):294-300. PubMed ID: 16818807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin-like oxidized LDL receptor-1 (LOX-1) acts as a receptor for remnant-like lipoprotein particles (RLPs) and mediates RLP-induced migration of vascular smooth muscle cells.
    Aramaki Y; Mitsuoka H; Toyohara M; Jinnai T; Kanatani K; Nakajima K; Mukai E; Yamada Y; Kita T; Inagaki N; Kume N
    Atherosclerosis; 2008 Jun; 198(2):272-9. PubMed ID: 18282574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Ox-LDL and LOX-1 in Atherogenesis.
    Kattoor AJ; Kanuri SH; Mehta JL
    Curr Med Chem; 2019; 26(9):1693-1700. PubMed ID: 29737246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.